New Purdue opioid crisis settlement builds ‘momentum' for Canada: B.C. AG
Recent settlements in U.S. government lawsuits against opioid manufacturer Purdue Pharma and the firm that allegedly consulted on boosting its sales have B.C.'s attorney general feeling 'heartened' as she pursues similar lawsuits in Canada.
Monday saw 55 U.S. states and territories reach a US$7.5-billion settlement with Purdue, the maker of OxyContin, and members of the Sackler family that sought to hold them accountable for contributing to the opioid overdose crisis.
As part of the settlement, the Sacklers will give up their control of the bankrupt company and will be barred from selling prescription opioids in the future.
A federal judge said Wednesday that he will rule Friday on a plan for local governments and individual victims, who would also be entitled to compensation, to vote on approving the settlement by September, allowing it to proceed.
Story continues below advertisement
The announcement of the U.S. settlement came after the B.C. Supreme Court on Friday certified a class-action lawsuit by the province against McKinsey & Company, which is accused of advising Purdue and other drugmakers on how to market their opioid products in Canada.
McKinsey has already had to pay over US$1 billion in penalties to settle similar lawsuits in the U.S., which also led to jail time for a McKinsey executive.
'I'm really pleased with the momentum,' B.C. Attorney General Niki Sharma told Global News in an interview.
'My job as attorney general is to make sure we pursue it very aggressively and as quickly as we can, so I am heartened by the success in the States and will keep on leading the charge here in Canada.'
The B.C. lawsuit against McKinsey is separate from a larger class action against dozens of opioid manufacturers and distributors on allegations they downplayed the risk their products posed in order to rake in profits. That lawsuit was allowed to go ahead last fall and was certified in January.
2:00
Supreme Court upholds B.C. opioid lawsuit
B.C. is leading both lawsuits on behalf of the other Canadian provinces and territories and the federal government, with the goal of recovering health-care costs that went toward responding to the overdose crisis, Sharma said.
Story continues below advertisement
'We think it's unfair that companies that profited so much, knowing that their product was so harmful and that would cause this level of addiction, aren't paying for the costs of health care,' she said.
A spokesperson for McKinsey told Global News it intends to defend itself against the lawsuit, which the company says is without merit.
'McKinsey did not undertake any work in Canada to enhance the sale or marketing of opioids,' the spokesperson said in an email.
Alleged tactics to 'turbocharge' opioid sales
B.C.'s lawsuit against McKinsey alleges the Canadian subsidiaries of Purdue, as well as Johnson & Johnson, Janssen and other drugmakers, employed many of the same tactics used by U.S. parent companies to boost their sales.
Get weekly health news
Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy
The B.C. Supreme Court, in certifying the lawsuit, noted in its decision that multinational companies often apply business and marketing strategies 'universally.'
Story continues below advertisement
Last December, McKinsey agreed to pay U$650 million to resolve a U.S. Justice Department lawsuit that focused on the firm's work with Purdue, including allegations that McKinsey advised on steps to 'turbocharge' sales of OxyContin.
Martin Elling, a former McKinsey senior partner who worked on Purdue matters, was sentenced to six months in prison after pleading guilty to obstruction of justice related to that case.
2:42
Conservatives grill Trudeau on former McKinsey head connection ahead of committee appearance
The federal settlement was on top of a combined US$641 million McKinsey agreed to pay in 2021 to resolve similar claims brought by U.S. state attorneys general.
In total, federal and state lawsuits related to the opioid crisis have resulted in roughly US$50 billion in settlements, according to researchers from Johns Hopkins University who track such claims.
Long-term heavy use of prescription painkillers like OxyContin due to dependence contributed to a majority of opioid-related hospitalizations and overdoses in the early 2000s across North America. In recent years, illicit opioids like fentanyl have overtaken prescription opioids as the primary driver of the opioid crisis.
Story continues below advertisement
Between 2016 and last September, nearly 51,000 Canadians have died of an opioid-related overdose, according to federal data. B.C., which declared a public health emergency in 2016, saw the most fatal overdoses of any other province during that time, with more than 16,000 deaths.
'I think like many provinces across this country, we've really seen the toll of the opioid crisis on people not only with long-lasting addictions and impacts there, but loss of life and a lot of people that are mourning the loss of their loved ones,' Sharma said.
A spokesperson for Health Canada said the federal government 'believes companies should be held accountable for their role in the overdose crisis' and will continue to work with provinces and territories on B.C.'s legal actions.
'The overdose crisis continues to be one of Canada's most pressing public health challenges,' the spokesperson said in an email to Global News.
Health Canada is reviewing and 'considering' developments from the recent Purdue settlement in the U.S., the statement added.
Where should the money go?
In 2022, B.C. secured a $150-million settlement on behalf of Canadian governments in a class action against Purdue. The settlement was finalized in early 2023, allowing individuals to submit claims from a $20-million portion set aside for victims and their families, a process that remains ongoing.
Story continues below advertisement
The pending lawsuit against opioid manufacturers and distributors names Purdue and its various subsidiaries, as well as Johnson & Johnson, Janssen and Canadian companies like Loblaw and its subsidiary Shoppers Drug Mart. It remains in litigation.
5:09
B.C. government steps up legal action against opioid drug makers
Researchers writing in the International Journal of Drug Policy earlier this year urged Canadian governments to ensure funds recovered from opioid lawsuit settlements go directly toward combating the drug crisis, rather than unrelated government expenses.
Those measures should include funding harm reduction services like overdose prevention centres and safe drug supplies, as well as community organizations that work directly with people suffering from addiction, the paper says.
Efforts to track how U.S. state and local governments are spending their opioid settlement money have uncovered several examples of funds not being used to directly respond to the opioid crisis.
Story continues below advertisement
Canada is being urged to avoid similar 'pitfalls' by mandating that at least 85 per cent of recovered funds be allocated to 'opioid remediation efforts,' and working directly with community organizations and members affected by addiction.
Proposed guidelines by researchers at Johns Hopkins University for how U.S. opioid settlement funds should be spent have been adopted in over 25 states, according to the university.
Sharma said B.C.'s lawsuits are structured so that any funds recovered by the province will be mandated to go to the health-care system, but that could evolve depending on how settlements are structured.
'It may be that as this develops, and the opioid cases develop, it will be tied to organizations that do addictions treatment, or there could be a whole range of things that go directly towards this crisis,' she said.
She pointed to the record $32.5-billion settlement B.C. won in March on behalf of Canadian governments in its lawsuit against the tobacco industry as a model both of the province's health-related legal advocacy and the results it can achieve.
'We are really focused on eliminating the bad actors,' she said.
'It's really important to make sure that we set a line in the sand about what's right and what isn't right with the conduct of all companies out there.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Winnipeg Free Press
33 minutes ago
- Winnipeg Free Press
Purdue Pharma's $7B opioid settlement plan could get votes from victims and cities
OxyContin maker Purdue Pharma 's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids will go before a judge Friday, potentially setting up votes on whether to accept it for local governments, people who became addicted to the drug and other groups. This month, 49 states announced they have signed on to the the proposal. Only Oklahoma, which has a separate settlement with the company, is not involved. U.S. Bankruptcy Court Judge Sean Lane could decide as soon as Friday whether to advance the nationwide settlement, which was hammered out in negotiations between the company, groups that have sued and representatives of members of the Sackler family who own the company. If Lane moves the plan forward as it's been presented, government entities, emergency room doctors, insurers, families of children born into withdrawal from the powerful prescription painkiller, individual victims and their families and others would have until Sept. 30 to vote on whether to accept the deal. The settlement is a way to avoid trials with claims from states alone that total more than $2 trillion in damages. If approved, the settlement would be among the largest in a wave of lawsuits over the past decade as governments and others sought to hold drugmakers, wholesalers and pharmacies accountable for the opioid epidemic that started rising in the years after OxyContin hit the market in 1996. The other settlements together are worth about $50 billion, and most of the money is to be used to combat the crisis. In the early 2000s, most opioid deaths were linked to prescription drugs, including OxyContin. Since then, heroin and then illicitly produced fentanyl became the biggest killers. In some years, the class of drugs was linked to more than 80,000 deaths, but that number dropped sharply last year. Monday Mornings The latest local business news and a lookahead to the coming week. Last year, the U.S. Supreme Court rejected a version of Purdue's proposed settlement. The court found it was improper to protect members of the Sackler family from lawsuits over opioids, even though they themselves were not filing for bankruptcy protection. In the new version, groups that don't opt in to the settlement would still have the right to sue members of the wealthy family whose name once adorned museum galleries around the world and programs at several prestigious U.S. universities. Under the plan, the Sackler family members would give up ownership of Purdue. They resigned from the company's board and stopped receiving distributions from its funds before the company's initial bankruptcy filing in 2019. The remaining entity would get a new name and its profits would be dedicated to battling the epidemic. Most of the money would go to state and local governments to address the nation's addiction and overdose crisis, but potentially more than $850 million would go directly to individual victims. That makes it different from the other major settlements. The payments would not begin until after a hearing, likely in November, during which Judge Lane would be asked to approve the entire plan if enough of the affected parties agree.
Global News
36 minutes ago
- Global News
Ontario teacher charged with assault, forcible confinement after 4 students kept in room
Peel Regional Police say a teacher is facing charges after four students were allegedly 'forcibly confined' in a room at a Mississauga, Ont. school. Police said an investigation was launched in May and the incident is alleged to have occurred during the current school year. The reported incident occurred at a public school in the area of Atwater Avenue and Cawthra Road. Get daily National news Get the day's top news, political, economic, and current affairs headlines, delivered to your inbox once a day. Sign up for daily National newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy Investigators allege the teacher 'physically moved' four students into a room and forcibly confined them, preventing them from leaving.' A 36-year-old man is facing four counts of assault and four counts of forcible confinement. Police said the accused was released with conditions and has another court appearance at a later date. The force also added that the Peel District School Board has confirmed the teacher is currently suspended pending the outcome of the court process. Story continues below advertisement 'Given the nature of the incident and the vulnerability of those involved, investigators are concerned there may be additional victims,' police said. 'Anyone with information, or who believes they or someone they know may have been affected, is urged to contact police.'
Vancouver Sun
39 minutes ago
- Vancouver Sun
Lululemon layoffs hint at tougher landscape for retail
Layoffs and reduced expectations at Vancouver apparel retailer Lululemon Athletica could be an indicator of tougher times generally for the entire sector at a time when consumers are becoming more pessimistic, according to one retail analyst. On Wednesday, Lululemon said it is laying off 150 employees at store support centres as it also reduced forecasts for profits for the year due to the challenging tariff environment imposed by U.S. President Donald Trump's global tariff war. The company is still expecting per-share profits of $14.58 US and $14.78 US per year, but if it is expecting sales to stagnate, it is likely Lululemon will want to show that it is taking control of what it can, said retail analyst David Ian Gray of the firm Dig360. Stay on top of the latest real estate news and home design trends. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Westcoast Homes will soon be in your inbox. Please try again Interested in more newsletters? Browse here. 'What you can do in a stagnant growth mode or a declining growth mode is work on your efficiencies, work on the cost side of the business and kind of maintain your bottom line,' Gray said. Generally, Canadian retailers have seen sales hold up in recent months, with Statistics Canada reporting retail sales of $70 billion in March, 5.6 per cent higher than in the same month a year ago. B.C. accounted for $9.4 billion of those March sales, which was a 4.7 per cent increase from a year ago. Greg Wilson, director of government relations for B.C. at the Retail Council of Canada, said results have been mixed. January and February were slow, but March results were good and the council expects April will be good as well, based on what they're hearing from members. 'Now, that said, B.C., they'd all say it was good, not remarkable by any means, just good,' Wilson said. 'But in the context of a tough economy, good is a pretty nice place to be.' Lululemon, however, has started to see lower in-store traffic, particularly in the U.S., company CEO Calvin McDonald said on the firm's latest conference call. The Conference Board of Canada's consumer confidence index has bounced back from an all-time low of 44.2 in March to 52.9 per cent in May, signalling a perception that uncertainties posed by global economic conditions have stabilized. Confidence, however, remains below the average rating and Gray said a lack of confidence lines up with consumers becoming 'budget conscious,' sticking to needs and foregoing wants, or at least substituting lower-cost items for premium brands. 'Even in terms of job stability and things like that, there are a lot of concerns,' Gray said. In its financial results earlier this month, the company said it planned strategic price increases as it deals with U.S. tariffs — passing along some of the costs to its customers. The price increases on products are expected to be modest and only apply to a few Lululemon products, but they reflect the lengths the business is having to go to shield itself from Trump's trade war and the pressure it's putting consumer spending, Meghan Frank, the company's chief financial officer, told analysts on a June 5 call. depenner@ With files from The Canadian Press
